KT Corp., South Korea's largest telecommunications company, is developing a COVID-19 infection risk assessment model, using its artificial intelligence (AI) and Big Data-based digital contact tracing technology, adding to global efforts to tackle the esca
Analytics 4 Life, which is developing a noninvasive, artificial intelligence-based platform that quickly diagnoses coronary artery disease, raised $25 million in series B financing to carry its device through clinical trials.